| Literature DB >> 26515254 |
Audrey Crousilles1, Eve Maunders1, Sean Bartlett2, Catherine Fan1, Emem-Fong Ukor3, Yassmin Abdelhamid1, Ysobel Baker2, Andres Floto3, David R Spring2, Martin Welch1.
Abstract
Over the last two decades, tens of millions of dollars have been invested in understanding virulence in the human pathogen, Pseudomonas aeruginosa. However, the top 'hits' obtained in a recent TnSeq analysis aimed at identifying those genes that are conditionally essential for infection did not include most of the known virulence factors identified in these earlier studies. Instead, it seems that P. aeruginosa faces metabolic challenges in vivo, and unless it can overcome these, it fails to thrive and is cleared from the host. In this review, we look at the kinds of metabolic pathways that the pathogen seems to find essential, and comment on how this knowledge might be therapeutically exploited.Entities:
Keywords: Pseudomonas aeruginosa; RNASeq; TnSeq; antimicrobial agents; cystic fibrosis; infection; metabolism; virulence
Mesh:
Substances:
Year: 2015 PMID: 26515254 DOI: 10.2217/fmb.15.100
Source DB: PubMed Journal: Future Microbiol ISSN: 1746-0913 Impact factor: 3.165